NasdaqGM:TRUP

Stock Analysis Report

Executive Summary

Trupanion, Inc., together with its subsidiaries, provides medical insurance for cats and dogs on monthly subscription basis in the United States, Canada, and Puerto Rico.

Snowflake

Fundamentals

Excellent balance sheet with reasonable growth potential.

Risks

  • Trupanion has significant price volatility in the past 3 months.

Share Price & News

How has Trupanion's share price performed over time and what events caused price changes?


Latest Share Price and Events


Market Performance


7 Day Return

2.0%

NasdaqGM:TRUP

1.2%

US Insurance

-0.02%

US Market


1 Year Return

-19.3%

NasdaqGM:TRUP

9.2%

US Insurance

1.6%

US Market

TRUP underperformed the Insurance industry which returned 9.9% over the past year.

TRUP underperformed the Market in United States of America which returned 1.9% over the past year.


Share holder returns

TRUPIndustryMarket
7 Day2.0%1.2%-0.02%
30 Day10.7%2.5%2.7%
90 Day-22.6%1.2%1.4%
1 Year-19.3%-19.3%11.8%9.2%3.8%1.6%
3 Year60.0%60.0%46.5%35.3%45.2%35.8%
5 Year226.8%226.8%71.5%50.9%61.8%44.1%

Price Volatility Vs. Market

How volatile is Trupanion's share price compared to the market and industry in the last 5 years?


Simply Wall St News

Valuation

Is Trupanion undervalued based on future cash flows and its price relative to the stock market?

7.19x

Price to Book (PB) ratio


Intrinsic Value Based on Future Cash Flows

Unable to calculate intrinsic value for Trupanion to establish if it is available at moderate discount.

Unable to calculate intrinsic value for Trupanion to establish if it is available at substantial discount.


Price Based on Earnings

Trupanion is loss making, we can't compare its value to the US Insurance industry average.

Trupanion is loss making, we can't compare the value of its earnings to the United States of America market.


Price Based on Expected Growth

Unable to calculate PEG ratio for Trupanion, we can't assess if its growth is good value.


Price Based on Value of Assets

Trupanion is overvalued based on assets compared to the US Insurance industry average.


Next Steps

Future Growth

How is Trupanion expected to perform in the next 1 to 3 years based on estimates from 8 analysts?

72.8%

Forecasted annual earnings growth


Earnings and Revenue Growth Estimates


Future Annual Growth Analysis

Trupanion's revenue is expected to grow by 17.9% yearly, however this is not considered high growth (20% yearly).

Trupanion's earnings are expected to grow significantly at over 20% yearly.

Trupanion's revenue growth is expected to exceed the United States of America market average.

Trupanion's earnings growth is expected to exceed the United States of America market average.

Trupanion's earnings growth is expected to exceed the low risk savings rate of 2.7%.


Earnings per Share Growth Estimates


Future Return on Equity

Unable to establish if Trupanion will efficiently use shareholders’ funds in the future without estimates of Return on Equity.


Next Steps

Past Performance

How has Trupanion performed over the past 5 years?

49.7%

Historical annual earnings growth


Earnings and Revenue History


Past Earnings Growth Analysis

Trupanion does not make a profit even though their year on year earnings growth rate was positive over the past 5 years.

Unable to compare Trupanion's 1-year earnings growth to the 5-year average as it is not currently profitable.

Unable to compare Trupanion's 1-year growth to the US Insurance industry average as it is not currently profitable.


Return on Equity

It is difficult to establish if Trupanion has efficiently used shareholders’ funds last year (Return on Equity greater than 20%) as it is loss-making.


Return on Assets

It is difficult to establish if Trupanion has efficiently used its assets last year compared to the US Insurance industry average (Return on Assets) as it is loss-making.


Return on Capital Employed

It is difficult to establish if Trupanion improved its use of capital last year versus 3 years ago (Return on Capital Employed) as it is currently loss-making.


Next Steps

Financial Health

How is Trupanion's financial position?


Financial Position Analysis

Trupanion is able to meet its short term (1 year) commitments with its holdings of cash and other short term assets.

Trupanion's cash and other short term assets cover its long term commitments.


Debt to Equity History and Analysis

Trupanion's level of debt (14.5%) compared to net worth is satisfactory (less than 40%).

Trupanion had negative shareholder equity 5 years ago, it is now positive therefore their debt level has improved.


Balance Sheet

High level of physical assets or inventory.

Debt is covered by short term assets, assets are 7.3x debt.


Cash Runway Analysis

For companies that have on average been loss making in the past we assess whether they have at least 1 year of cash runway.

Trupanion has sufficient cash runway for 2.2 years based on current free cash flow.

Unable to confirm if Trupanion has at least 1 year of cash runway based on growing free cash flows without relevant data.


Next Steps

Dividend

What is Trupanion's current dividend yield, its reliability and sustainability?


Dividend Yield and Payments Analysis

Unable to evaluate Trupanion's dividend yield against the bottom 25% of dividend payers as the company has not reported any payouts.

Unable to evaluate Trupanion's dividend against the top 25% market benchmark as the company has not reported any payouts.

Unable to perform a dividend volatility check as Trupanion has not reported any payouts.

Unable to verify if Trupanion's dividend has been increasing as the company has not reported any payouts.


Current Payout to Shareholders

Unable to calculate sustainability of dividends as Trupanion has not reported any payouts.


Future Payout to Shareholders

Insufficient estimate data to determine if a dividend will be paid in 3 years and that it will be sustainable.


Next Steps

Management

What is the CEO of Trupanion's salary, the management and board of directors tenure and is there insider trading?

3.3yrs

Average management tenure


CEO

Darryl Graham Rawlings (50yo)

19.7yrs

Tenure

US$875,631

Compensation

Mr. Darryl Graham Andrew Rawlings Co-founded Trupanion, Inc.(also known as Vetinsurance International Inc) in 2000 and has been its Chief Executive Officer, President and Director since January 2001. Mr. R ...


CEO Compensation Analysis

Darryl Graham's remuneration is lower than average for companies of similar size in United States of America.

Darryl Graham's compensation has increased whilst company is loss making.


Management Age and Tenure

3.3yrs

Average Tenure

41yo

Average Age

The tenure for the Trupanion management team is about average.


Board Age and Tenure

8.0yrs

Average Tenure

62yo

Average Age

The tenure for the Trupanion board of directors is about average.


Insider Trading

No 3 month open market individual insider trading information.


Recent Insider Transactions

SellUS$443,43004 Jun 19
Daniel Levitan
EntityIndividual
Role
Member of the Board of Directors
Director
Shares15,000
Max PriceUS$29.56
SellUS$779,33728 Feb 19
Howard Rubin
EntityIndividual
Role
Member of the Board of Directors
Director & Consultant
Shares26,043
Max PriceUS$30.05
SellUS$344,29126 Feb 19
Howard Rubin
EntityIndividual
Role
Member of the Board of Directors
Director & Consultant
Shares11,457
Max PriceUS$30.05
SellUS$75,00026 Feb 19
Howard Rubin
EntityIndividual
Role
Member of the Board of Directors
Director & Consultant
Shares2,500
Max PriceUS$30.00
SellUS$1,215,82226 Nov 18
Howard Rubin
EntityIndividual
Role
Member of the Board of Directors
Director & Consultant
Shares45,000
Max PriceUS$27.04
BuyUS$25,43915 Nov 18
Jacqueline Davidson
EntityIndividual
Role
Member of the Board of Directors
Director
Shares1,000
Max PriceUS$25.44
BuyUS$486,35315 Nov 18
Robin Ferracone
EntityIndividual
Role
Member of the Board of Directors
Director
Shares19,000
Max PriceUS$25.60

Ownership Breakdown


Management Team

  • Howard Rubin (66yo)

    Director & Consultant

    • Tenure: 9.5yrs
    • Compensation: US$155.86k
  • Darryl Graham Rawlings (50yo)

    Founder

    • Tenure: 19.7yrs
    • Compensation: US$875.63k
  • Ian Moffat (43yo)

    Head of Food Initiatives

    • Tenure: 0.3yrs
    • Compensation: US$816.04k
  • Thomas Houk (31yo)

    Chief Member Experience Officer

    • Tenure: 3.3yrs
    • Compensation: US$747.97k
  • Tricia Plouf (40yo)

    Chief Financial Officer

    • Tenure: 3.3yrs
    • Compensation: US$817.48k
  • Asher Bearman (41yo)

    Chief Strategy Officer & Corporate Secretary

    • Tenure: 0.7yrs
    • Compensation: US$814.55k
  • Margi Tooth (40yo)

    Chief Revenue Officer

    • Tenure: 0.7yrs
    • Compensation: US$816.15k
  • Laura Bainbridge

    Head of Investor Relations

    • Tenure: 4.7yrs
  • Gavin Friedman

    SVP of Regulatory & General Counsel

    • Tenure: 1.7yrs
  • Scott Janzen

    Director of Communications

    • Tenure: 0yrs

Board Members

  • Dan Levitan (62yo)

    Director

    • Tenure: 12.4yrs
    • Compensation: US$74.26k
  • Jackie Davidson (59yo)

    Director

    • Tenure: 1yrs
    • Compensation: US$19.74k
  • Murray Low (66yo)

    Chairman of the Board

    • Tenure: 0yrs
    • Compensation: US$84.14k
  • Hays Lindsley (60yo)

    Director

    • Tenure: 6.6yrs
    • Compensation: US$74.26k
  • Howard Rubin (66yo)

    Director & Consultant

    • Tenure: 9.5yrs
    • Compensation: US$155.86k
  • Robin Ferracone (66yo)

    Director

    • Tenure: 4.8yrs
    • Compensation: US$84.14k
  • Darryl Graham Rawlings (50yo)

    Founder

    • Tenure: 19.7yrs
    • Compensation: US$875.63k
  • Bill Williams

    Member of Veterinary Advisory Board

    • Tenure: 0yrs
  • Robert Totman

    Member of Veterinary Advisory Board

    • Tenure: 0yrs
  • I. Prior

    Member of Veterinary Advisory Board

    • Tenure: 0yrs

Company Information

Trupanion, Inc.'s company bio, employee growth, exchange listings and data sources


Key Information

  • Name: Trupanion, Inc.
  • Ticker: TRUP
  • Exchange: NasdaqGM
  • Founded: 2000
  • Industry: Life and Health Insurance
  • Sector: Insurance
  • Market Cap: US$942.465m
  • Shares outstanding: 34.79m
  • Website: https://www.trupanion.com

Number of Employees


Location

  • Trupanion, Inc.
  • 6100 4th Avenue South
  • Suite 200
  • Seattle
  • Washington
  • 98108
  • United States

Listings

TickerExchangePrimary SecuritySecurity TypeCountryCurrencyListed on
TRUPNasdaqGM (Nasdaq Global Market)YesCommon StockUSUSDJul 2014
TPWDB (Deutsche Boerse AG)YesCommon StockDEEURJul 2014
0LH0LSE (London Stock Exchange)YesCommon StockGBUSDJul 2014

Biography

Trupanion, Inc., together with its subsidiaries, provides medical insurance for cats and dogs on monthly subscription basis in the United States, Canada, and Puerto Rico. The company operates through Subsc ...


Company Analysis and Financial Data Status

All financial data provided by Standard & Poor's Capital IQ.
DataLast Updated (UTC time)
Company Analysis2019/09/19 00:44
End of Day Share Price2019/09/18 00:00
Earnings2019/06/30
Annual Earnings2018/12/31


Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.